A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma

NCT03810976 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Eribulin, gemcitabine

Sponsor

Yonsei University